🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
12 mg (75% DV)
✅ Within RDA (0.9× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 12mg UL 35mg
NITRIX 2.0 Proprietary Blend
3.6 Gram(s)

Other Ingredients

Stearic Acid Microcrystalline Cellulose Hydroxypropyl Methylcellulose Magnesium Stearate Croscarmellose Sodium Polydextrose Silicon Dioxide Hydroxypropyl Cellulose Red 40 Yellow 6 Titanium Dioxide Blue 2

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 3 tablets 2 times per day.

⚠️ Warnings & Precautions

Warning: Consult your physician before using this product if you are taking any medications or are under a physician's care for a medical condition. Not for use by those under the age of 18, women that are pregnant, trying to get pregnant, or nursing, or those that are sensitive to niacin.

Not for use by those under the age of 18, women that are pregnant, trying to get pregnant, or nursing, or those that are sensitive to niacin. Keep out of reach of children.

🧪 Formulation Notes

NITRIX 2.0 supports workout performance, endurance, pumps and recovery with 3 grams of the amino acid L-citrulline, a precursor to nitric oxide, and 3g of creatine when taken as directed.

Pteropure & Resvida

3g Creatine per day 3g L-Citrulline per day

Additional Information

Store in a dry place away from direct sunlight.

This product has been manufactured by a Good Manufacturing Practices (GMP) facility.

V.3.518.0318US 6046154

Pumps Recovery Performance

Concentrated nitric oxide precursor

Made in the USA

This product contains ingredients of international and domestic origin

Product Details

UPC / SKU 8 34266 00518 5
DSLD Entry Date 2019-02-25
Product Type Other Combinations
Form Tablet or Pill
Brand BSN
DSLD ID 184099
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →